Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.56 |
| ▸ | CA12 | O43570 | 5/20 | 0.56 |
| ▸ | CA7 | P43166 | 5/20 | 0.56 |
| ▸ | CA9 | Q16790 | 5/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | XDH | P47989 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11782629 | 0.92 | KDM4E (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL11785375 | 0.84 | KDM4E (0.41) | CA1CA2CA12CA7CA9 | |
| SCHEMBL5161494 | 0.82 | KDM4E (0.65) | CA1CA2CA12CA7CA9 | |
| SCHEMBL10945485 | 0.82 | CA1 (0.56) | CA1CA2CA12CA7CA9 | |
| SCHEMBL29086835 | 0.81 | LCK (0.57) | CA1CA2CA12CA7CA9 | |
| SCHEMBL6512713 | 0.80 | CA1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL22828496 | 0.80 | CA1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL95955 | 0.80 | CA1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL147169 | 0.80 | CA1 (0.71) | CA1CA2CA12CA7CA9 | |
| SCHEMBL15936293 | 0.79 | ALDH1A1 (0.58) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3954840-A | THERMAL STABILITY | TEIJIN LTD. (JA) | 1976-05-04 | — | — | US | claimed |
| US-9676686-B2 | Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device | JNC CORPORATION (JP) | 2017-06-13 | — | — | US | disclosed |
| US-9631142-B2 | Piperidine derivative, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-04-25 | — | — | US | disclosed |
| US-20160208172-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING NITROGEN-CONTAINING CYCLIC COMPOUND AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20160090534-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-03-31 | — | — | US | disclosed |
| EP-0263705-B1 | THE USE OF THERMOPLASTIC POLYESTER RESIN COMPOSITION FOR UV-SCREENING | MITSUBISHI KASEI CORPORATION (JP) | 1993-06-30 | — | — | EP | disclosed |
| US-4814366-A | ULTRAVIOLET SCREENING AGENTS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1989-03-21 | — | — | US | disclosed |
| EP-0263705-A2 | The use of thermoplastic polyester resin composition for UV-screening | MITSUBISHI KASEI CORPORATION (JP) | 1988-04-13 | — | — | EP | disclosed |
| US-3954840-A | THERMAL STABILITY | TEIJIN LTD. (JA) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160090534-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | MBD2, SSB, MBTD1 | CA1 725/4885CA2 2140/4885CA12 3265/4885 |
| US-20160208172-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING NITROGEN-CONTAINING CYCLIC COMPOUND AND LIQUID CRYSTAL DISPLAY DEVICE | CCND2, ROCK2, CCND1 | CA1 953/4885CA2 972/4885CA12 1249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.